Engaging Industry Partners to Strengthen Diversity in Cancer Research
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...
Throughout his career as a cancer researcher, Robert A. Winn, MD, has seen a familiar pattern in progress. Each...
Glioblastoma is an aggressive form of brain cancer. Less than 5 percent of patients diagnosed with this cancer type...
Since 2014, the American Association for Cancer Research (AACR) has invited early-career investigators to apply to the NextGen Stars program, which provides awardees the opportunity to present their...
Racial/ethnic inequities in cancer are well documented. Not only are Black Americans more likely to die of cancer than white Americans, but Black and Hispanic individuals are...
In 2019, Michael D. Story, PhD, vice chair of the Department of Radiation Oncology and chief of the Division of Molecular Radiation Biology at UT Southwestern Medical Center, was one of...
Epithelial ovarian cancer is by far the most common ovarian cancer subtype, accounting for 90 percent of ovarian cancers. The...
Earlier this year, the American Association of Cancer Research (AACR) partnered with Novocure, a global oncology company, to launch...
Providing a forum for innovative cancer researchers around the world, Singapore will hold its 11th Frontiers in Cancer Science...
Since its inception in 1993, the American Association of Cancer Research (AACR) Grants Program, in partnership with other nonprofit...
This spring, in the inaugural year of the American Association for Cancer Research (AACR) Global-Scholar-In-Training Awards (GSITA) program, 15...